INDICATION AND EFFECT:
NutriLock™ is approved for instillation in all central venous access systems. NutriLock™ remaining in the catheter prevents the formation of a bacterial biofilm. The catheter stays infection-free.
NutriLock™ contains taurolidine (2%) which has a broad antimicrobial activity against gram-positive and gram-negative bacteria (incl. MRSA and VRE) and fungi (e.g. Candida).
NutriLock™ is available in 3 mL ampoules (single use): 10 ampoules per box.
NutriLock™ complies with the recommendations for the use of antimicrobial lock solutions (see literature). We recommend TauroLock™-Hep500 for dialysis access systems.
During application-free periods (oncology, parenteral nutrition), NutriLock™ is instilled into the saline-rinsed access system. The filling volume of the catheter/port system should be noted in this context.
Before the next application, the lock solution is to be aspirated with a syringe, the system is then to be rinsed with saline. If it is not possible to aspirate the lock solution, NutriLock™ can be flushed out with saline. Due to the rapid degradation of taurolidine, there is no systemic effect.
The use of NutriLock™ is contraindicated in patients with known taurolidine allergy and in patients concurrently taking drugs that have been demonstrated to undergo undesirable interactions with taurolidine.
NutriLock™ must be stored at 15 to 25°C, and must be neither transported nor stored under freezing conditions.
This information does not supplant the Instructions for use.